Hussman Strategic Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,150
| Closed | -$1.47M | – | 309 |
|
|
2024
Q3 | $1.47M | Hold |
3,150
| – | – | 0.36% | 119 |
|
|
2024
Q2 | $1.48M | Hold |
3,150
| – | – | 0.41% | 107 |
|
|
2024
Q1 | $1.32M | Hold |
3,150
| – | – | 0.31% | 123 |
|
|
2023
Q4 | $1.28M | Sell |
3,150
-4,650
| -60% | -$1.89M | 0.29% | 135 |
|
|
2023
Q3 | $2.71M | Hold |
7,800
| – | – | 0.52% | 65 |
|
|
2023
Q2 | $2.74M | Sell |
7,800
-4,600
| -37% | -$1.62M | 0.51% | 54 |
|
|
2023
Q1 | $3.91M | Hold |
12,400
| – | – | 0.61% | 32 |
|
|
2022
Q4 | $3.58M | Hold |
12,400
| – | – | 0.58% | 51 |
|
|
2022
Q3 | $3.59M | Hold |
12,400
| – | – | 0.62% | 40 |
|
|
2022
Q2 | $3.49M | Buy |
12,400
+9,800
| +377% | +$2.76M | 0.6% | 39 |
|
|
2022
Q1 | $679K | Hold |
2,600
| – | – | 0.13% | 223 |
|
|
2021
Q4 | $571K | Sell |
2,600
-6,700
| -72% | -$1.47M | 0.13% | 231 |
|
|
2021
Q3 | $1.69M | Hold |
9,300
| – | – | 0.37% | 111 |
|
|
2021
Q2 | $1.88M | Buy |
9,300
+2,100
| +29% | +$423K | 0.39% | 99 |
|
|
2021
Q1 | $1.55M | Buy |
7,200
+2,100
| +41% | +$451K | 0.32% | 116 |
|
|
2020
Q4 | $1.21M | Buy |
+5,100
| New | +$1.21M | 0.32% | 126 |
|